Results 61 to 70 of about 1,656 (194)

Case Report: A Case of Severe Clinical Deterioration in a Patient With Multiple Sclerosis [PDF]

, 2020
Tumefactive multiple sclerosis (MS) is a rare variant of MS that may lead to a rapidly progressive clinical deterioration requiring a multidisciplinary diagnostic workup.
Aktas, Orhan, Albrecht, Philipp, Aytulun, Aykut, Breitkopf, Katharina, Brueck, Wolfgang, Foerster, Moritz, Goebels, Norbert, Hartung, Hans-Peter, Hefter, Harald, Huppert, Doreen, Kraus, Bastian, Metz, Imke, Reifenberger, Guido, Turowski, Bernd   +13 more
core   +1 more source

Errors in neuroradiology [PDF]

, 2015
Approximately 4 % of radiologic interpretation in daily practice contains errors and discrepancies that should occur in 2-20 % of reports. Fortunately, most of them are minor degree errors, or if serious, are found and corrected with sufficient ...
Briganti, F, Brunese, L, Caranci, F, Gatta, G, Leone, G, Pinto, A, Reginelli, A, Squillaci, E, Tedeschi, E   +8 more
core   +2 more sources

Neuro-oncology dilemma: Tumour or tumefactive demyelinating lesion [PDF]

Multiple Sclerosis and Related Disorders, 2015
Tumefactive demyelinating lesions (TDLs) are not an uncommon manifestation of demyelinating disease but can pose diagnostic challenges in patients without a pre-existing diagnosis of multiple sclerosis (MS) as well as in known MS patients. Brain tumours can also arise in MS patients and can be seen in chronic MS patients as co-morbidities.
Mohammad, Abdoli, Mark S, Freedman
openaire   +2 more sources

Quantitative Assessment of Upper Limb Ataxia Using a Virtual Reality‐Based Evaluation System

Annals of Clinical and Translational Neurology, Volume 13, Issue 1, Page 180-192, January 2026.
ABSTRACT Objective Cerebellar ataxia impairs coordination and balance, reducing quality of life. Conventional clinical scales, including the Scale for the Assessment and Rating of Ataxia (SARA) and the International Cooperative Ataxia Rating Scale (ICARS), are widely used to assess ataxia but are limited by subjectivity and inter‐rater variability ...
Masayuki Sato, Takayuki Abe, Sho Aoki, Setsuki Tsukagoshi, Yasushi Yuminaka, Yoshio Ikeda   +5 more
wiley   +1 more source

Marburg variant of multiple sclerosis; a diagnostic and therapeutic challenge [PDF]

, 2015
Marburg variant of multiple sclerosis (MS) is a highly aggressive, fulminant demyelinating disease with very high morbidity and mortality. Early diagnosis and aggressive management is vital to limit severe disability and improve the outcome. We present a
Imtiaz, Sadia, MD, Arsalan Ahmad, Siddiqui, Maimoona   +2 more
core   +1 more source

Advanced Imaging Applications in Tumefactive Demyelination – Literature Review With an Illustrative Case Report

Clinical Neuroimaging, Volume 3, Issue 1, 2026.
ABSTRACT Background and Purpose Solitary tumefactive demyelinating lesions (TDLs) represent an uncommon but clinically significant manifestation of central nervous system demyelination and pose a major diagnostic challenge due to their radiologic resemblance to high‐grade gliomas, primary central nervous system lymphoma, and other mass‐like lesions ...
Joga Chaganti, Michelle Dellalana, Kiran Talekar, Jay Thakkar, Scott H. Faro   +4 more
wiley   +1 more source

Progression of tumefactive demyelinating lesion in a child demonstrated with MRI

Radiology Case Reports, 2018
Tumefactive demyelinating lesions (TDLs) are atypical presentations of various demyelinating diseases. They can mimic brain tumors in their clinical and radiological features and usually respond favorably to corticosteroid therapy.
Marta De Simone, MD, Barbara Brogna, MD, Daniele Litterio Spitaleri, MD, Giulio Cicarelli, MD, Roberta Fantozzi, MD, Bruno Guida, MD   +5 more
doaj   +1 more source

Evaluating brain damage in multiple sclerosis with simultaneous multi‐angular‐relaxometry of tissue

Annals of Clinical and Translational Neurology, 2022
Objective Multiple sclerosis (MS) is a common demyelinating central nervous system disease. MRI methods that can quantify myelin loss are needed for trials of putative remyelinating agents.
Biao Xiang, Jie Wen, Robert E. Schmidt, Alexander L. Sukstanskii, Daniel Mamah, Dmitriy A. Yablonskiy, Anne H. Cross   +6 more
doaj   +1 more source

Double Anti‐NMO and Anti‐MOG Positivity in a Patient With Metastatic Renal Carcinoma: First Reported Case

Case Reports in Neurological Medicine, Volume 2026, Issue 1, 2026.
Background Neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein‐associated disease (MOGAD) are central nervous system (CNS) demyelinating disorders characterized by autoantibodies targeting aquaporin‐4 (AQP4) and MOG, respectively.
M. Fortanet García, A. Belenguer Benavides, S. Blanco Madera, H. Benetó Andrés, A. Monclus Beclua, A. Recio Gimeno, L. Popova, Isabella Laura Simone   +7 more
wiley   +1 more source

Pitfalls in the diagnosis of a tumefactive demyelinating lesion: A case report

Journal of Medical Case Reports, 2011
Introduction In rare instances, demyelinating disorders manifest as tumefactive lesions that simulate brain tumors. We report a patient with a space-occupying lesion in the parietal lobe, which presented a serious diagnostic dilemma, between a rare ...
Sakas Damianos, C Stavrinou Lampis, Boviatsis Efstathios, Gavra Maria   +3 more
doaj   +1 more source